?

Arbuckle Stuart A

Director
ImmunoGen, Inc.
US, Waltham [HQ]
CIK 1557290

Data Source

We automatically created this profile. The information was aggregated based on earnings call transcripts, insider forms and DEF 14A statements.

Latest Information

Shares :
63,532
Price per Share :
$419.92
Equivalence :
$26,678,357.44

Transaction History

  • A
    Form 4
    63,532 Shares After Transaction
    Value : $n/a
    $0.0
    02/06/24
  • Footnotes:
    #1 Represents earned performance shares with respect to a performance stock unit award granted on 02/03/2021 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 02/06/2024 and the shares will vest on 02/20/2024.
    #2 Represents earned performance shares with respect to a performance stock unit award granted on 02/01/2023 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 02/06/2024 and the shares will vest in installments beginning on 02/10/2024.
    #3 Restricted stock unit award that vests in installments beginning on 02/17/2025.
  • A
    Form 4
    74,742 Shares After Transaction
    Value : $n/a
    $0.0
    02/06/24
  • A
    Form 4
    83,190 Shares After Transaction
    Value : $n/a
    $0.0
    02/07/24
  • A
    Form 4
    5,381 Shares After Transaction
    Value : $159,546.65
    $13,105.30
    12/29/23
  • S
    Form 4
    49,691 Shares After Transaction
    Value : $21,413,342.63
    Sold $29,734.17
    05/15/24

Get PRO Today.

PRO unlocks 9 more insider transactions made by Arbuckle Stuart A

Start Free PRO trial Subscribe to PRO